UNITY Complete® Fetal Risk Screen

The New Standard In Prenatal Care.

One blood draw for multiple insights. No male partner sample required for an accurate fetal risk.

Pregnant woman smiling with her hands around her stomach

Discover What Sets UNITY Complete Apart.

UNITY Complete Fetal Risk Screen is prenatal screening reimagined. It has earned a spot in AJHG’s Genomic Medicine Year in Review: 2023, recognized as a top 10 key advancement in applying genomics to clinical care.¹

Know More. Know Early.

Identifying potential genetic conditions at the earliest stages is not just about preparation, it's about empowerment.

Request a Test Kit

UNITY Complete® accessible and affordable for all.

  • We accept all insurances, including Medicaid
  • We are in network with the majority of insurance plans

Early Intervention

UNITY Complete provides early detection of severe genetic conditions, early in a pregnancy. Knowing early allows access to timely interventions and treatments.

Informed Decisions

Knowledge is empowerment. You and your healthcare team can make informed and confident decisions about your care and management.

Peace Of Mind

99% of patients will learn there is a low chance that a baby will be born with certain genetic conditions2.

Preparation For Parenthood

Early insights enable you to prepare for the emotional, mental, and practical considerations for your new baby.

Take The Next Step With UNITY Complete.

Whether you are a provider looking to order your first UNITY Complete test, or an expectant parent wanting to know more, we are here to support your journey.

Are you a patient?
Get Started
A doctor reviewing results with a mom

Providers

Learn about the tests, access peer-reviewed publications, and more
Get Provider Information
A pregnant woman using a tablet

Patients

Learn more about what to expect with UNITY Complete
Get Patient Information

References

  1. 1. Teri A. Manolio, et al. Genomic medicine year in review: 2023, The American Journal of Human Genetics, Volume 110, Issue 12, Pages 1992-1995, https://doi.org/10.1016/j.ajhg.2023.11.001.

  2. 2. Wynn J, et al. Performance of single-gene noninvasive prenatal testing for autosomal recessive conditions in a general population setting. Prenat Diagn. 2023 Sep; 43(10):1344-1354. doi: 10.1002/pd.6427. Epub 2023 Sep 6. PMID: 37674263